<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00196105</url>
  </required_header>
  <id_info>
    <org_study_id>03-MOZ</org_study_id>
    <nct_id>NCT00196105</nct_id>
  </id_info>
  <brief_title>Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)</brief_title>
  <official_title>Multicenter Prospective Randomized Controlled Trial of the Nitinol ZILVER Expandable Endoprosthesis in the Palliation of Extrahepatic Malignant Biliary Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook Group Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook Group Incorporated</source>
  <brief_summary>
    <textblock>
      This study compares the 6 mm nitinol Zilver biliary endoprostheses and the 10 mm nitinol
      Zilver biliary endoprostheses to the 10 mm Wallstent in appropriate patients in need of
      palliative treatment of malignant obstructive jaundice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research is being done to determine if the new, FDA-cleared Zilver metal biliary stent
      is better than the conventional stents. The new Zilver stent may permit more accurate
      placement, may avoid some potential complications and last longer than the conventional
      stents. The study will also examine to find the best diameter of stent by comparing standard
      10 mm stents to 6 mm Zilver stents.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patency</measure>
    <time_frame>up to 32 months</time_frame>
    <description>Number of days of stent patency: The time to stent occlusion requiring re-intervention, death, loss to follow-up, or patients alive at study end without an occlusion (&gt;= 6 months after placement).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Closure or Blockage of the Stent (Occlusion)</measure>
    <time_frame>up to 32 months</time_frame>
    <description>Biliary stents may become closed or blocked. This is also termed &quot;Occlusion.&quot; Data for this outcome measure involve stent occlusions that required re-intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Days to Occlusion</measure>
    <time_frame>up to 32 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Deaths</measure>
    <time_frame>up to 32 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Death</measure>
    <time_frame>up to 32 months</time_frame>
    <description>Overall Survival</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">241</enrollment>
  <condition>Biliary Tract Neoplasms</condition>
  <condition>Pancreatic Neoplasms</condition>
  <condition>Jaundice, Obstructive</condition>
  <arm_group>
    <arm_group_label>6 mm Zilver</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 mm Nitinol Zilver Stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 mm Zilver</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 mm Nitinol Zilver Stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 mm Wallstent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 mm Stainless Steel Wallstent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>6 mm Nitinol Zilver Stent</intervention_name>
    <arm_group_label>6 mm Zilver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>10 mm Nitinol Zilver Stent</intervention_name>
    <arm_group_label>10 mm Zilver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>10 mm Stainless Steel Wallstent</intervention_name>
    <arm_group_label>10 mm Wallstent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unresectable malignancy of the extrahepatic bile duct

        Exclusion Criteria:

          -  Age below 21 years

          -  Pregnancy

          -  Active alcohol or drug abuse

          -  Simultaneously participating in another investigational drug or device study.

          -  Allergy to stainless steel or nitinol

          -  Active cholangitis

          -  Brachytherapy

          -  Unable or unwilling to comply with follow up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas Howell, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maine Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, Shah RJ, Chen YK, Parsons WG, Hawes RH, Cotton PB, Slivka AA, Ahmad J, Lehman GA, Sherman S, Neuhaus H, Schumacher BM. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 2009 Sep;70(3):445-53. doi: 10.1016/j.gie.2008.11.018. Epub 2009 May 30.</citation>
    <PMID>19482279</PMID>
  </results_reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <results_first_submitted>September 25, 2009</results_first_submitted>
  <results_first_submitted_qc>January 11, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 12, 2010</results_first_posted>
  <last_update_submitted>September 28, 2011</last_update_submitted>
  <last_update_submitted_qc>September 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stents</keyword>
  <keyword>Stent-graft</keyword>
  <keyword>Minimally invasive</keyword>
  <keyword>Biliary Tract Cancer</keyword>
  <keyword>Pancreatic Cancer</keyword>
  <keyword>Jaundice</keyword>
  <keyword>Biliary Tract Neoplasms</keyword>
  <keyword>Pancreatic Neoplasms</keyword>
  <keyword>Jaundice, Obstructive</keyword>
  <keyword>Zilver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Biliary Tract Neoplasms</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>6 mm Zilver</title>
          <description>6 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="P2">
          <title>10 mm Zilver</title>
          <description>10 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="P3">
          <title>10 mm Wallstent</title>
          <description>10 mm Stainless Steel Wallstent</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="88"/>
                <participants group_id="P3" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="83"/>
                <participants group_id="P3" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>6 mm Zilver</title>
          <description>6 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="B2">
          <title>10 mm Zilver</title>
          <description>10 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="B3">
          <title>10 mm Wallstent</title>
          <description>10 mm Stainless Steel Wallstent</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="64"/>
            <count group_id="B2" value="88"/>
            <count group_id="B3" value="89"/>
            <count group_id="B4" value="241"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71.3" lower_limit="41" upper_limit="90"/>
                    <measurement group_id="B2" value="72.8" lower_limit="48" upper_limit="94"/>
                    <measurement group_id="B3" value="71.5" lower_limit="49" upper_limit="96"/>
                    <measurement group_id="B4" value="71.9" lower_limit="41" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="115.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="126.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Biliary Sphincterotomy</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Patients with Biliary Sphincterotomy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without Biliary Sphincterotomy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Plastic Stent</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Patients with Previous Plastic Stent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without Previous Plastic Stent</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tumor Diagnosis</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Patients with Pancreatic Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with Metastatic Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with Cholangiocarcinoma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with Gallbladder Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients with Other Cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patients without Tumor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bilirubin</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.6" spread="8.7"/>
                    <measurement group_id="B2" value="8.7" spread="7.3"/>
                    <measurement group_id="B3" value="8.3" spread="8.7"/>
                    <measurement group_id="B4" value="8.8" spread="8.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Karnofsky Index</title>
          <description>The Karnofsky index runs from 100 to 0, where 100 is &quot;perfect&quot; health and 0 is death.</description>
          <units>Units on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80.5" spread="9.5"/>
                    <measurement group_id="B2" value="80.6" spread="9.9"/>
                    <measurement group_id="B3" value="81.2" spread="9.2"/>
                    <measurement group_id="B4" value="80.8" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patency</title>
        <description>Number of days of stent patency: The time to stent occlusion requiring re-intervention, death, loss to follow-up, or patients alive at study end without an occlusion (&gt;= 6 months after placement).</description>
        <time_frame>up to 32 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 mm Zilver</title>
            <description>6 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O2">
            <title>10 mm Zilver</title>
            <description>10 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O3">
            <title>10 mm Wallstent</title>
            <description>10 mm Stainless Steel Wallstent</description>
          </group>
        </group_list>
        <measure>
          <title>Patency</title>
          <description>Number of days of stent patency: The time to stent occlusion requiring re-intervention, death, loss to follow-up, or patients alive at study end without an occlusion (&gt;= 6 months after placement).</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="88"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110" lower_limit="7" upper_limit="595"/>
                    <measurement group_id="O2" value="125.5" lower_limit="5" upper_limit="671"/>
                    <measurement group_id="O3" value="121" lower_limit="0" upper_limit="961"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.057</p_value>
            <method>Log Rank</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Closure or Blockage of the Stent (Occlusion)</title>
        <description>Biliary stents may become closed or blocked. This is also termed &quot;Occlusion.&quot; Data for this outcome measure involve stent occlusions that required re-intervention.</description>
        <time_frame>up to 32 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 mm Zilver</title>
            <description>6 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O2">
            <title>10 mm Zilver</title>
            <description>10 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O3">
            <title>10 mm Wallstent</title>
            <description>10 mm Stainless Steel Wallstent</description>
          </group>
        </group_list>
        <measure>
          <title>Closure or Blockage of the Stent (Occlusion)</title>
          <description>Biliary stents may become closed or blocked. This is also termed &quot;Occlusion.&quot; Data for this outcome measure involve stent occlusions that required re-intervention.</description>
          <units>Stent Occlusions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="88"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.04</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.007</p_value>
            <p_value_desc>Death is censored for Kaplan-Meier analysis.</p_value_desc>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.69</p_value>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>6 mm Zilver vs. 10 mm Zilver and 10 mm Wallstent combined</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.02</p_value>
            <p_value_desc>P-value is adjusted for multiple comparisons.</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Days to Occlusion</title>
        <time_frame>up to 32 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 mm Zilver</title>
            <description>6 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O2">
            <title>10 mm Zilver</title>
            <description>10 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O3">
            <title>10 mm Wallstent</title>
            <description>10 mm Stainless Steel Wallstent</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days to Occlusion</title>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115" lower_limit="7" upper_limit="595"/>
                    <measurement group_id="O2" value="111" lower_limit="6" upper_limit="506"/>
                    <measurement group_id="O3" value="103" lower_limit="7" upper_limit="386"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.16</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Deaths</title>
        <time_frame>up to 32 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 mm Zilver</title>
            <description>6 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O2">
            <title>10 mm Zilver</title>
            <description>10 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O3">
            <title>10 mm Wallstent</title>
            <description>10 mm Stainless Steel Wallstent</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Deaths</title>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="88"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Death</title>
        <description>Overall Survival</description>
        <time_frame>up to 32 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>6 mm Zilver</title>
            <description>6 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O2">
            <title>10 mm Zilver</title>
            <description>10 mm Nitinol Zilver Stent</description>
          </group>
          <group group_id="O3">
            <title>10 mm Wallstent</title>
            <description>10 mm Stainless Steel Wallstent</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Death</title>
          <description>Overall Survival</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="88"/>
                <count group_id="O3" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132.6" lower_limit="74" upper_limit="328"/>
                    <measurement group_id="O2" value="186" lower_limit="92" upper_limit="304"/>
                    <measurement group_id="O3" value="170" lower_limit="99" upper_limit="273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.32</p_value>
            <method>Log Rank</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.69</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>No adverse events were captured due to terminal patients.</desc>
      <group_list>
        <group group_id="E1">
          <title>6 mm Zilver</title>
          <description>6 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="E2">
          <title>10 mm Zilver</title>
          <description>10 mm Nitinol Zilver Stent</description>
        </group>
        <group group_id="E3">
          <title>10 mm Wallstent</title>
          <description>10 mm Stainless Steel Wallstent</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Scott Snyder</name_or_title>
      <organization>Cook</organization>
      <phone>765-463-7537</phone>
      <email>ssnyder@medinst.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

